4.5 Article

Crystal Structure of Sphingosine Kinase 1 with PF-543

期刊

ACS MEDICINAL CHEMISTRY LETTERS
卷 5, 期 12, 页码 1329-1333

出版社

AMER CHEMICAL SOC
DOI: 10.1021/ml5004074

关键词

SPHK1; PF-543; SPHK2; sphingosine; lipid; S1P

资金

  1. Structural Genomics Consortium [1097737]
  2. AbbVie
  3. Bayer
  4. Boehringer Ingelheim
  5. Canada Foundation for Innovation
  6. Canadian Institutes for Health Research
  7. Genome Canada
  8. GlaxoSmithKline
  9. Janssen
  10. Lilly Canada
  11. Novartis Research Foundation
  12. Ontario Ministry of Economic Development and Innovation
  13. Pfizer
  14. Takeda
  15. Wellcome Trust [092809/Z/10/Z]

向作者/读者索取更多资源

The most potent inhibitor of Sphingosine Kinase 1 (SPHK1) so far identified is PF-543. The crystal structure of SPHK1 in complex with inhibitor PF-543 to 1.8 angstrom resolution reveals the inhibitor bound in a bent conformation analogous to that expected of a bound sphingosine substrate but with a rotated head group. The structural data presented will aid in the design of SPHK1 and SPHK2 inhibitors with improved properties.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据